Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE)

NCT02750800 · clinicaltrials.gov ↗

COMPLETED

Status

427

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis
Ankylosing Spondylitis
Psoriatic Arthritis
Psoriasis
Crohn's Disease
Ulcerative Colitis

Interventions

BIOLOGICAL: Adalimumab
BEHAVIORAL: AbbVie Care 2.0

Sponsor

AbbVie